BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7752292)

  • 1. Users of free treatment slots at a community-based methadone maintenance clinic.
    Wells EA; Fleming C; CalsyƄ DA; Jackson TR; Saxon AJ
    J Subst Abuse Treat; 1995; 12(1):13-8. PubMed ID: 7752292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an AIDS prevention education program for health service providers working with i.v. drug users.
    Nelson FL; Kabacy M
    J Subst Abuse; 1989; 1(4):467-70. PubMed ID: 2485292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.
    King VL; Burke C; Stoller KB; Neufeld KJ; Peirce J; Kolodner K; Kidorf M; Brooner RK
    J Subst Abuse Treat; 2008 Oct; 35(3):312-21. PubMed ID: 18294805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-site medical care in methadone maintenance: associations with health care use and expenditures.
    Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ
    J Subst Abuse Treat; 2007 Mar; 32(2):143-51. PubMed ID: 17306723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone medical maintenance in primary care. An implementation evaluation.
    Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
    J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
    Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
    Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
    Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
    Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge of and interest in hepatitis C treatment at a methadone clinic.
    Walley AY; White MC; Kushel MB; Song YS; Tulsky JP
    J Subst Abuse Treat; 2005 Mar; 28(2):181-7. PubMed ID: 15780548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug czar seeks new emphasis on methadone treatment.
    AIDS Policy Law; 1997 Oct; 12(20):7. PubMed ID: 11364789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone maintenance treatment. When and how to refer patients.
    DeMaria PA; Weinstein SP
    Postgrad Med; 1995 Mar; 97(3):83-6, 91-2. PubMed ID: 7877931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR; Lea T; Sheridan J
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of outcome in methadone programs: effect of HIV counseling and testing.
    Farley TA; Cartter ML; Wassell JT; Hadler JL
    Conn Med; 1994 Mar; 58(3):165-71. PubMed ID: 8039381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methadone treatment: experience and progress].
    Newman RG
    Verh Dtsch Ges Inn Med; 1990; 96():583-8. PubMed ID: 2092485
    [No Abstract]   [Full Text] [Related]  

  • 18. Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization.
    Barnett PG; Masson CL; Sorensen JL; Wong W; Hall S
    Addiction; 2006 Dec; 101(12):1797-804. PubMed ID: 17156179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug substitution program in Zurich].
    Fuchs WJ
    Verh Dtsch Ges Inn Med; 1990; 96():606-9. PubMed ID: 2092490
    [No Abstract]   [Full Text] [Related]  

  • 20. Methadone maintenance treatment: outcomes from the Otago methadone programme.
    Dore GM; Walker JD; Paice JR; Clarkson S
    N Z Med J; 1999 Nov; 112(1100):442-5. PubMed ID: 10678242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.